We've updated our Privacy Policy to make it clearer how we use your personal data.

We use cookies to provide you with a better experience, read our Cookie Policy

Spencer Pharmaceutical Signs Agreement With Univalor, L.P.

News   Mar 11, 2011

 
Spencer Pharmaceutical Signs Agreement With Univalor, L.P.
 
 
 

RELATED ARTICLES

Yeast Model of Metabolic Disorders May Lead to Novel Therapies

News

Researchers suggests that the role of yeast, the world's most basic eukaryotic unicellular organism, may pave the way for the development of novel, more effective therapies for the treatment of metabolic disorders.

READ MORE

Making Plastic from Poo!

News

A new, fossil-free bioplastic is emerging. According to lab experiments, it is more durable than both regular plastic and other bioplastics, and is potentially better suited for recycling.

READ MORE

Poo Transplant Shows Promise in Prelim Study for Ulcerative Colitis

News

Anaerobically prepared fecal microbiota transplantation improved remission rates in people with moderately active ulcerative colitis at 8 weeks. Further research is needed to assess longer-term efficacy and safety.

READ MORE

 

Like what you just read? You can find similar content on the communities below.

Applied Sciences Biopharma Proteomics & Metabolomics

To personalize the content you see on Technology Networks homepage, Log In or Subscribe for Free

LOGIN SUBSCRIBE FOR FREE